Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo
/in Dendritic Cells, International PublicationsThe efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: a local experience
/in Acute Leukemia, Dendritic Cells, International PublicationsOptimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy
/in Dendritic Cells, International PublicationsNovel therapeutic strategies for treating esophageal adenocarcinoma: the potential of dendritic cell immunotherapy and combinatorial regimens
/in Dendritic Cells, Esophageal Carcinoma, International PublicationsDendritic cell vaccines in metastasized malignant melanoma
/in Dendritic Cells, International Publications, Malignant MelanomaVaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients
/in Dendritic Cells, Glioblastoma, International PublicationsAlterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2
/in Breast Cancer, Dendritic Cells, International PublicationsMaximizing dendritic cell migration in cancer immunotherapy
/in Dendritic Cells, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer